Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

TAK-676 Alone and in Combination(s) With Carboplatin, 5-Fluorouracil, and Paclitaxel in Patients With Head and Neck Squamous Cell Carcinoma

NCT06062602 is registered in ClinicalTrials.gov with Presage Biosciences as lead sponsor.

NCT NCT06062602
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT06062602 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
TAK-676 Alone and in Combination(s) With Carboplatin, 5-Fluorouracil, and Paclitaxel in Patients With Head and Neck Squamous Cell Carcinoma
Lead sponsor
Presage Biosciences
Phase
Phase 1
Overall status
Completed
Start date
July 26, 2021
Completion date
November 15, 2022
Enrollment
15 (actual)
Sites
4

Conditions

As the registry lists them; a condition with its own page is linked.

head and neck squamous cell carcinoma